What is the standard dose range for RAD-140 in a documented research protocol?

The standard dose range for RAD-140 runs from 5 mg/day at entry level up to 20 mg/day at the upper boundary. Most structured protocols use 10 mg/day as the mid-range reference point, with 5 mg entry phases recommended for first-time users to assess individual response before increasing. Master Pharma's 10 mg tablet covers the mid-range dose in a single unit.

How long should a RAD-140 cycle last before taking a break?

Most research-consistent protocols cap RAD-140 cycles at 8 weeks, with 10 weeks as the upper limit before suppression depth becomes a recovery concern. A 60-tablet supply at 10 mg/day maps precisely to one 8-week cycle. After the active phase, an equivalent rest period — typically 8 weeks — is observed before repeating, verified by a post-cycle blood panel showing LH recovery to baseline.

Why is time-off after a RAD-140 cycle as important as the cycle itself?

Time-off allows the hypothalamic-pituitary-gonadal axis to restore endogenous androgen production suppressed during the active phase. Running cycles back-to-back without recovery intervals risks compounding suppression across cycles. Post-cycle blood work measuring LH, FSH, and total testosterone at four to six weeks off provides objective confirmation that recovery is complete before a new cycle starts.

How should Master Pharma RAD-140 tablets be stored to maintain dose accuracy across a full 8-week cycle?

Store tablets in their original blister packaging at room temperature, away from direct light, heat above 25 °C, and humidity. The individual blister cell format isolates each tablet until point of use, preserving the 10 mg active load through the full shelf life. Do not transfer tablets to a secondary container, as ambient moisture exposure can degrade active content.

Can the 10 mg tablet be split to achieve a 5 mg introductory dose?

Yes — the tablet can be split with a pill cutter to deliver a 5 mg entry dose for the first one to two weeks of a cycle. This allows the user to assess individual androgen receptor sensitivity before moving to the full 10 mg daily dose. HPLC-verified content uniformity across the tablet means each half delivers a consistent portion of the stated 10 mg active load. (2) angle_used

Top Seller

Master Pharma

Testolone (RAD-140) 10mg/tab 60 Tablets by Master Pharma

Name: Testolone (RAD-140)
Brand: Master Pharma
SKU: SARM-TEST-MAS-004
Price: 60.00 EUR
Availability: InStock

Master Pharma Testolone (RAD-140) delivers 10 mg of Testolone per tablet across a 60-tablet blister pack, formulated as a precision oral SARM for structured cycle planning around defined dose ranges, cycle lengths, and mandatory time-off intervals. Each tablet supports an evidence-informed protocol framework — typical 8-week active phases followed by equal rest periods — making dose management straightforward for research use. HPLC active-content verification and GMP-compliant production are applied lot-specifically; every batch released carries quantified analytical clearance before dispatch.

€60.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Delivers analytically verified 10 mg RAD-140 per tablet via lot-specific HPLC release testing
60-tablet count aligns exactly with a single 8-week protocol at 10 mg/day
Tablet format eliminates liquid measurement error for precise daily dose tracking
Selective androgen receptor binding targets skeletal muscle with reduced off-target androgenic activity
Individual blister cell packaging preserves each dose from production through point of use
Supports mid-range dosing in one unit or entry-level dosing via half-tablet splitting
GMP-compliant manufacturing provides the production consistency required for structured research use

Phase	Dosage	Note
Entry (Weeks 1–2)	5 mg/day (half tablet)	Assess individual AR sensitivity before escalating
Standard (Weeks 3–8)	10 mg/day (1 tablet)	Core protocol phase; covers full 60-tablet supply at this dose
Advanced (Weeks 1–8)	15–20 mg/day	Experienced users only; requires closer post-cycle monitoring
Time-Off (Weeks 9–16)	0 mg	Mandatory recovery; confirm LH/testosterone recovery by blood panel at week 12–14

Key takeaways

Follow an 8-week active cycle matched by an equal 8-week recovery window.
Start dosing at 5 mg/day and titrate up based on individual response.
Confirm axis recovery with a post-cycle blood panel before repeating.
Use HPLC-verified tablets to maintain accurate dose calculations throughout.
Track LH and total testosterone at baseline and post-cycle for protocol accountability.

RAD-140 as a Protocol-Driven Compound: Dose, Duration, and Recovery

Testolone (RAD-140) is a selective androgen receptor modulator whose responsible use depends entirely on structured protocol design — defined entry doses, capped cycle lengths, and enforced time-off windows — rather than intuitive dosing. Master Pharma supplies RAD-140 in a 10 mg tablet unit that maps directly onto the standard dose increments used in current research protocols, removing the need for splitting or compounding. RAD-140 binds selectively to androgen receptors in skeletal muscle and bone, producing anabolic signalling with reduced androgenic activity compared to testosterone at equivalent receptor-occupancy doses.

Standard Dose Ranges and How the 10 mg Unit Fits

Research-consistent dose ranges for RAD-140 run from 5 mg/day at the conservative entry point up to 20 mg/day at the upper boundary of commonly documented protocols. The 10 mg tablet format covers both: a single tablet delivers the mid-range dose most commonly reported in structured use, while half-tablet administration — achievable with a pill cutter — supports 5 mg introductory phases. Compared to liquid SARM suspensions, fixed-dose tablets eliminate volume measurement error and deliver the same active load per unit across the full 60-tablet supply. HPLC quantification confirms active content per tablet against a RAD-140-specific reference standard, so the stated 10 mg is analytically verified, not nominal.

Cycle Length and Time-Off Planning

The standard active cycle for RAD-140 runs 8 weeks in most documented research frameworks; extending beyond 10 weeks is associated with progressively deeper suppression of endogenous androgen signalling, measured by serum LH and total testosterone decline from baseline. A 60-tablet supply at 10 mg/day covers exactly one 8-week cycle, which is structurally intentional: the pack size aligns with the recommended cycle boundary. Time-off planning follows a 1:1 ratio — eight weeks on requires eight weeks off before a subsequent cycle begins, allowing the hypothalamic-pituitary-gonadal axis sufficient recovery time, as indicated by post-cycle blood panels tracking LH recovery to pre-cycle baseline.

Monitoring and Protocol Accountability

Blood work represents the objective checkpoint in any RAD-140 protocol: a pre-cycle baseline panel (total testosterone, LH, FSH, haematocrit) establishes reference values, and a post-cycle panel drawn four to six weeks after the last tablet confirms axis recovery before the next cycle is considered. Master Pharma's lot-specific HPLC release data supports this accountability framework — when a researcher knows the tablet content is analytically verified, dose calculations and protocol timelines carry quantifiable precision.

Usage

Draw a pre-cycle blood panel — total testosterone, LH, FSH, haematocrit — to establish your individual baseline values before the first tablet.
Begin at 5 mg/day (half tablet) for the first two weeks to evaluate individual receptor sensitivity and tolerability.
Advance to 10 mg/day (one full tablet) from week three onward; take at the same time each day to maintain consistent plasma levels across RAD-140's approximately 60-hour half-life.
Cap the active cycle at 8 weeks; the 60-tablet pack is sized precisely for this duration at the standard 10 mg dose.
After the last tablet, begin the time-off period — equal in length to the active cycle — and schedule a follow-up blood panel at 4–6 weeks post-cycle to confirm LH and testosterone recovery.
Do not begin a subsequent cycle until blood panel values confirm full axis recovery to pre-cycle baseline.

Warnings

Contraindications: Not for use by individuals under 21, women of childbearing potential, or those with existing endocrine disorders, hepatic impairment, or hormone-sensitive conditions. Discontinue immediately if signs of virilisation or significant haematocrit elevation appear.

Side Effects: Potential effects include endogenous testosterone suppression, elevated haematocrit, altered lipid markers (HDL reduction), and transient fatigue during the time-off phase. Severity correlates with dose magnitude and cycle length.

Monitoring: Run comprehensive blood panels at three checkpoints: pre-cycle baseline, mid-cycle (week 4 for cycles at 15–20 mg/day), and post-cycle at 4–6 weeks. Track LH, FSH, total testosterone, and haematocrit at minimum.

PCT: Depending on post-cycle blood panel results, a PCT protocol using a SERM (e.g. tamoxifen or enclomiphene) may be required if LH and testosterone remain suppressed beyond 6 weeks post-cycle. Consult an endocrinologist or sports medicine physician before initiating any PCT agent.

Frequently asked questions

What is the standard dose range for RAD-140 in a documented research protocol?: The standard dose range for RAD-140 runs from 5 mg/day at entry level up to 20 mg/day at the upper boundary. Most structured protocols use 10 mg/day as the mid-range reference point, with 5 mg entry phases recommended for first-time users to assess individual response before increasing. Master Pharma's 10 mg tablet covers the mid-range dose in a single unit.
How long should a RAD-140 cycle last before taking a break?: Most research-consistent protocols cap RAD-140 cycles at 8 weeks, with 10 weeks as the upper limit before suppression depth becomes a recovery concern. A 60-tablet supply at 10 mg/day maps precisely to one 8-week cycle. After the active phase, an equivalent rest period — typically 8 weeks — is observed before repeating, verified by a post-cycle blood panel showing LH recovery to baseline.
Why is time-off after a RAD-140 cycle as important as the cycle itself?: Time-off allows the hypothalamic-pituitary-gonadal axis to restore endogenous androgen production suppressed during the active phase. Running cycles back-to-back without recovery intervals risks compounding suppression across cycles. Post-cycle blood work measuring LH, FSH, and total testosterone at four to six weeks off provides objective confirmation that recovery is complete before a new cycle starts.
How should Master Pharma RAD-140 tablets be stored to maintain dose accuracy across a full 8-week cycle?: Store tablets in their original blister packaging at room temperature, away from direct light, heat above 25 °C, and humidity. The individual blister cell format isolates each tablet until point of use, preserving the 10 mg active load through the full shelf life. Do not transfer tablets to a secondary container, as ambient moisture exposure can degrade active content.
Can the 10 mg tablet be split to achieve a 5 mg introductory dose?: Yes — the tablet can be split with a pill cutter to deliver a 5 mg entry dose for the first one to two weeks of a cycle. This allows the user to assess individual androgen receptor sensitivity before moving to the full 10 mg daily dose. HPLC-verified content uniformity across the tablet means each half delivers a consistent portion of the stated 10 mg active load. (2) angle_used

Manufacturer

RAD-140's physicochemical properties — including its chromatographic behaviour and stability profile — dictate how Master Pharma approaches raw material qualification for this specific SKU: incoming API is assessed against identity and purity parameters defined specifically for Testolone's molecular structure, not carried over from a shared SARM template. The origin of each API batch is documented through the supply chain, and only lots meeting Master Pharma's RAD-140-specific acceptance criteria enter tableting. Once manufactured, the finished 10 mg tablets undergo HPLC active-content verification run against a RAD-140-matched reference standard — confirming that the stated dose is analytically present in every released production lot rather than inferred from formulation records alone.

Product details

Brand	Master Pharma
Active ingredient	testolone
Also known as	Testolone (RAD-140), Master Pharma Testolone (RAD-140)
Strength	10 mg
Form	Tabletten
Pack size	60 pieces
Item number	SARM-TEST-MAS-004

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Testolone 10mg/tab 60 Tablets by Elbrus Pharmaceuticals

Lab Tested

Testolone 10mg/tab 60 Tabletten by Elbrus Pharmaceuticals

Testolone (RAD-140) is a non-steroidal selective androgen receptor modulator from Elbrus Pharmaceuticals, formulated at 10mg per tablet to deliver the highest published anabolic-to-androgenic ratio among characterised SARMs — a distinction that places precise dosing at the centre of responsible use. Skeletal muscle and bone androgen receptors are activated selectively, supporting lean mass accumulation without estrogenic conversion or the hepatotoxic burden associated with 17-alpha-alkylated oral compounds. Each production batch clears two independent analytical gates — finished-product HPLC potency confirmation and LAL endotoxin screening — before any tablets are authorised for distribution.

€70.00

Testolone 15mg/tab 50 Tablets by Rich Piana 5% Nutrition

HPLC Verified

Testolone 15mg/tab 50 Tabletten by Rich Piana 5% Nutrition

Rich Piana 5% Nutrition Testolone delivers RAD-140 at 15 mg per tablet — a selective androgen receptor modulator clinically noted for its capacity to drive hypothalamic-pituitary-testicular axis (HPTA) suppression even at moderate research doses, making structured recovery planning a central part of any responsible cycle. Each blister-packed tablet offers one of the highest per-dose concentrations available in this compound class, reducing pill burden while keeping daily intake precise. Batch-level potency and safety are validated through a sequential HPLC quantification and LAL endotoxin-screening protocol before a single tablet reaches the end user.

€65.00

Batch Tested

Testolone 5mg/tab 30 Tablets by Vital Research

Vital Research Testolone delivers RAD-140 at 5 mg per tablet across a 30-tablet blister — a precision low-dose format purpose-built for stacking strategies, where fine-grained dosing control determines whether a stack leans toward aggressive bulking or lean-tissue preservation during a cut. Each tablet slots directly into goal-phase protocols: paired with LGD-4033 for maximum anabolic output in a bulk, or layered alongside Ostarine and Cardarine for a fat-loss stack that defends muscle mass. Batch Tested for identity and potency via HPLC; LAL endotoxin testing and GMP-aligned tableting round out the quality chain.

€48.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00